European Journal of Chemistry 2018, 9(3), 168-177 | doi: https://doi.org/10.5155/eurjchem.9.3.168-177.1735 | Get rights and content

Issue cover




Crossmark

  Open Access OPEN ACCESS | Open Access PEER-REVIEWED | RESEARCH ARTICLE | DOWNLOAD PDF | VIEW FULL-TEXT PDF | TOTAL VIEWS

Cytotoxic, antiglycation and carbonic anhydrase inhibition studies of chromium(III)-aroylhydrazine complexes


Bushra Shamshad (1) orcid , Rifat Ara Jamal (2) orcid , Uzma Ashiq (3,*) orcid , Mohammad Mahroof-Tahir (4) orcid , Muhammad Saleem (5) orcid

(1) Department of Chemistry, Faculty of Science, University of Karachi, Karachi, 75270, Pakistan
(2) Department of Chemistry, Faculty of Science, University of Karachi, Karachi, 75270, Pakistan
(3) Department of Chemistry, Faculty of Science, University of Karachi, Karachi, 75270, Pakistan
(4) Department of Chemistry and Earth Sciences, Faculty of Science, Qatar University, 2713, Doha, Qatar
(5) Department of Chemistry, University of Education, Lahore, Dera Ghazi Khan Campus, 32200, Dera Ghazi Khan, Pakistan
(*) Corresponding Author

Received: 15 May 2018 | Revised: 06 Jun 2018 | Accepted: 11 Jun 2018 | Published: 30 Sep 2018 | Issue Date: September 2018

Abstract


In order to further reveal the chemistry and biochemistry of chromium(III) complexes, the present work illuminates the formation of chromium(III) complexes with aroylhydrazine ligands with their physical, chemical and spectral studies. Another significant contribution of this study is the evaluation of the cytotoxic activity, antiglycation property and carbonic anhydrase inhibition study of synthesized chromium(III)-aroylhydrazine complexes. Synthesis and structural investigation of aroylhydrazine ligands (1-7) and their chromium(III) complexes (1a-7a) were carried out by using elemental analysis (C, H, N), physical (conductivity measurements) and spectral (EI-Mass, ESI-Mass, FTIR and UV-Visible) methods. These physical, analytical and spectral data supports that all chromium(III)-aroylhydrazine complexes exhibit an octahedral geometry in which ligand exhibits as a bidentate coordination and two water molecules coordinated at equatorial positions with general formula [Cr(L)2(H2O)2]Cl3. Cytotoxic investigations shows that synthesized chromium(III)-aroylhydrazine complexes were not found to be toxic against normal cells so these compounds were further studied for other biological activities. Moreover, aroylhydrazine ligands and their chromium(III) complexes were examined for their antiglycation activity in which ligands were found inactive whereas chromium(III)-aroylhydrazine complexes showed significant inhibition of the process of protein glycation. Similarly, in carbonic anhydrase inhibition studies all aroylhydrazine ligands were observed inactive while some of chromium(III)-aroylhydrazine complexes showed potential in carbonic anhydrase inhibition.


Keywords


Cytotoxicity; Antiglycation; Aroylhydrazine; Biological studies; Carbonic anhydrase; Chromium(III)-complex

Full Text:

PDF
PDF    Open Access

DOI: 10.5155/eurjchem.9.3.168-177.1735

Links for Article


| | | | | | |

| | | | | | |

| | | |

Related Articles




Article Metrics

icon graph This Abstract was viewed 908 times | icon graph PDF Article downloaded 274 times

Funding information


Higher Education Commission (HEC) (The National Research Grants Program for Universities, Grant No. 1862/R&D/10), Pakistan

References


[1]. Anderson, R. A. Diabetes Metab. 2000, 26, 22-27.

[2]. Anderson, R. A.; Cheng, N.; Bryden, N. A.; Polansky, M. M.; Cheng, N.; Chi, J.; Feng, J. Diabetes. 1997, 46, 1786-1791.
https://doi.org/10.2337/diab.46.11.1786

[3]. Hininger, I.; Benaraba, R.; Osman, M.; Faure, H.; Roussel, A. M.; Anderson, R. A. Free Radic. Biol. Med. 2007, 42, 1759-1765.
https://doi.org/10.1016/j.freeradbiomed.2007.02.034

[4]. Hummel, M.; Standl, E.; Schnell, O. Horm. Metab. Res. 2007, 39, 743-751.
https://doi.org/10.1055/s-2007-985847

[5]. Wang, Z. Q.; Qin, J.; Martin, J.; Zhang, X. H.; Sereda, O.; Anderson, R. A.; Pinsonat, P.; Cefalu, W. T. Metabolism. 2007, 56, 1652-1655.
https://doi.org/10.1016/j.metabol.2007.07.007

[6]. Raja, N. S.; Sankaranarayanan, K.; Dhathathreyan, A.; Nair, B. U. BBA-Biomembranes 2011, 1808, 332-340.

[7]. Ara, R.; Ashiq, U.; Mahroof‐Tahir, M.; Maqsood, Z. T.; Khan, K. M.; Lodhi, M. A.; Choudhary, M. I. Chem. Biodivers. 2007, 4, 58-71.
https://doi.org/10.1002/cbdv.200790007

[8]. Ashiq, U.; Ara, R.; Mahroof‐Tahir, M.; Maqsood, Z. T.; Khan, K. M.; Khan, S. N.; Siddiqui H.; Choudhary, M. I. Chem. Biodivers. 2008, 5, 82-92.
https://doi.org/10.1002/cbdv.200890016

[9]. Ashiq, U.; Jamal, R. A.; Mahroof-Tahir, M.; Maqsood, Z. T.; Khan, K. M.; Omer, I.; Choudhary, M. I. J. Enzym. Inhib. Med. Chem. 2009, 24, 1336-1343.
https://doi.org/10.3109/14756360902888168

[10]. Ashiq, U.; Jamal R. A.; Mesaik M. A.; Mahroof-Tahir M.; Shahid S.; Khan K. M. Med. Chem. 2014, 10, 287-299.
https://doi.org/10.2174/15734064113099990033

[11]. Ain, Q. U.; Ashiq, U.; Jamal, R. A.; Mahrooof-Tahir, M. Spectrochim. Acta A. 2013, 115, 683-689.
https://doi.org/10.1016/j.saa.2013.05.064

[12]. Ain, Q. U.; Ashiq, U.; Jamal, R. A.; Saleem, M.; Mahrooof-Tahir, M. Arab. J. Chem. 2015, 10, 488-499.

[13]. Shamshad, B.; Jamal, R. A.; Ashiq, U.; Mahrooof-Tahir, M.; Shaikh, Z.; Sultan, S.; Khan, K. M. Med. Chem. 2015, 11, 798-806.
https://doi.org/10.2174/1573406411666150401103442

[14]. Shaikh, Z; Ashiq, U.; Jamal, R. A.; Mahrooof-Tahir, M.; Shamshad, B.; Sultan, S. Transit. Metal Chem. 2015, 40, 665-671.
https://doi.org/10.1007/s11243-015-9960-z

[15]. Sultan, S.; Ashiq, U.; Jamal, R. A.; Mahroof-Tahir, M.; Shaikh, Z.; Shamshad, B.; Lateef, M.; Iqbal, L. BioMetal. 2017, 30, 873-891.
https://doi.org/10.1007/s10534-017-0054-6

[16]. Kimbrough, D. E.; Cohen, Y.; Winer, A. M.; Creelman, L.; Mabuni, C. Crit. Rev. Env. Sci. Technol. 1999, 29, 1-46.
https://doi.org/10.1080/10643389991259164

[17]. DG, B. Clin. Toxicol. 1999, 37, 173-194.

[18]. Mertz, W. J. Am. Coll. Nutr. 1998, 17, 544-547.
https://doi.org/10.1080/07315724.1998.10718801

[19]. Shrivastava, H. Y.; Ravikumar, T.; Shanmugasundaram, N.; Babu, M.; Nair, B. U. Free Radic. Biol. Med. 2005, 38, 58-69.
https://doi.org/10.1016/j.freeradbiomed.2004.09.029

[20]. Bianchi, V.; Levis, A. G. Sci. Total Environ. 1988, 71, 351-355.
https://doi.org/10.1016/0048-9697(88)90207-0

[21]. O'Brien, T. J.; Ceryak, S.; Patierno, S. R. Mutat. Res. Fund. Mol. M. 2003, 533, 3-36.
https://doi.org/10.1016/j.mrfmmm.2003.09.006

[22]. Tuman, R. W.; Doisy, R. J. Diabetes. 1977, 26, 820-826.
https://doi.org/10.2337/diab.26.9.820

[23]. Vincent, J. The Nutritional Biochemistry of Chromium(III). Amsterdem, The Netherlands: Elsevier. 2011.

[24]. Ahmed, N.Diabetes Res. Clin. Pract. 2005, 67, 3-21.
https://doi.org/10.1016/j.diabres.2004.09.004

[25]. Rahbar, S.; Figarola, J. L. Arch. Biochem. Biophys. 2003, 419, 63-79.
https://doi.org/10.1016/j.abb.2003.08.009

[26]. Jamil, W.; Solangi, S.; Ali, M.; Khan, K. M.; Taha, M.; Khuhawar, M. Y. Arab. J. Chem. 2015, inpress, doi: 10.1016/j.arabjc.2015.02.015
https://doi.org/10.1016/j.arabjc.2015.02.015

[27]. Kandemirli, F.; Rasheed. S.; Sayiner, H. S.; Akkaya, Y.; Dogan, C.; Vurdua.; Choudhary, M. I. J. Chem. Pharm. Res. 2015, 7, 44-55.

[28]. Supuran, C. T. Nat. Rev. Drug Discov. 2008, 7, 168-181.
https://doi.org/10.1038/nrd2467

[29]. Alterio, V.; Vitale, R. M.; Monti, S. M.; Pedone, C.; Scozzafava, A.; Cecchi, A.; De Simone, G.; Supuran, C. T. J. Am. Chem. Soc. 2006, 128, 8329-8335.
https://doi.org/10.1021/ja061574s

[30]. Nishimori, I.; Minakuchi, T.; Onishi, S.; Vullo, D.; Scozzafava, A.; Supuran, C. T. J. Med. Chem. 2007, 50, 381-388.
https://doi.org/10.1021/jm0612057

[31]. Nishimori, I.; Vullo, D.; Innocenti, A.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Bioorg. Med. Chem. Lett. 2005, 15, 3828-3833.
https://doi.org/10.1016/j.bmcl.2005.06.055

[32]. Vullo, D.; Franchi, M.; Gallori, E.; Antel, J.; Scozzafava, A.; Supuran, C. T. J. Med. Chem. 2004, 47, 1272-1279.
https://doi.org/10.1021/jm031057+

[33]. Vullo, D.; Innocenti, A.; Nishimori, I.; Pastorek, J. R.; Scozzafava, A.; Pastoreková, S.; Supuran, C. T. Bioorg. Med. Chem. Lett. 2005, 15, 963-969.
https://doi.org/10.1016/j.bmcl.2004.12.053

[34]. Senturk, M.; Talaz, O.; Ekinci, D.; Cavdar, H.; Kufrevioglu, O. I. Bioorg. Med. Chem. Lett. 2009, 19, 3661-3663.
https://doi.org/10.1016/j.bmcl.2009.04.087

[35]. Kohler, K.; Hillebrecht, A.; Schulze Wischeler, J.; Innocenti, A.; Heine, A.; Supuran, C. T.; Klebe, G. Angew. Chem. Int. Edit. 2007, 46, 7697-7699.
https://doi.org/10.1002/anie.200701189

[36]. Saczewski, F.; Slawinski, J.; Kornicka, A.; Brzozowski, Z.; Pomarnacka, E.; Innocenti, A.; Scozzafava, A.; Supuran, C. T. Bioorg. Med. Chem. Lett. 2006, 16, 4846-4851.
https://doi.org/10.1016/j.bmcl.2006.06.064

[37]. Supuran, C. T.; Scozzafava, A.; Conway, J. Carbonic Anhydrase: its Inhibitors and Activators: CRC Press. 2004.
https://doi.org/10.4324/9780203475300

[38]. Supuran, C. T.; Scozzafava, A.; Ilies, M. A.; Briganti, F. J. Enzyme Inhib. Med. Chem. 2000, 15, 381-401.

[39]. Briganti, F.; Tilli, S.; Mincione, G.; Mincione, F.; Menabuoni, L.; Supuran, C. T. J. Enzym. Inhib. 2000, 15, 185-200.
https://doi.org/10.1080/14756360009030350

[40]. Ilies, M.; Scozzafava, A.; Supuran, C. T. Carbonic Anhydrase Activators: CRC Press: Boca Raton (FL), USA. 2004.
https://doi.org/10.4324/9780203475300_chapter_12

[41]. Mastrolorenzo, A.; Scozzafava, A.; Supuran, C. T. J. Enzyme Inhib. 2000, 15, 517-531.
https://doi.org/10.3109/14756360009040707

[42]. Sumalan, S.; Casanova, J.; Alzuet, G.; Borras, J.; Castineiras, A.; Supuran, C. J. Inorg. Biochem. 1996, 62, 31-39.
https://doi.org/10.1016/0162-0134(95)00086-0

[43]. Supuran, C. Rev. Roum. Chim. 1992, 37, 849-855.

[44]. Supuran, C.; Scozzafava, A.; Briganti, F.; Ilies, M.; Jitianu, A. Met. Based Drugs. 1998, 5, 103-114.
https://doi.org/10.1155/MBD.1998.103

[45]. Supuran, C. T. Met. Based Drugs. 1995, 2, 331-336.
https://doi.org/10.1155/MBD.1995.331

[46]. Supuran, C. T.; Andruh, M.; Manole, G. J. Inorg. Biochem. 1993, 49, 97-103.
https://doi.org/10.1016/0162-0134(93)85019-5

[47]. Jeffery, G.; Bassett, J.; Mendham, J. D.; Denney, R. C. Vogel's Textbook of Quantitative Chemical Analysis: Longman, New York. 1989.

[48]. Mosmann, T. J. Immunol. Methods. 1983, 65, 55-63.
https://doi.org/10.1016/0022-1759(83)90303-4

[49]. Dariusz, S.; Sarah, J. S.; Richard, H. C.; Michael, B. J. Immunol. Methods. 1993, 157, 203-207.
https://doi.org/10.1016/0022-1759(93)90088-O

[50]. Lee, C.; Yim, M. B.; Chock, P. B.; Yim, H. S.; Kang S. O. J. Biol. Chem. 1998, 273, 25272-25278.
https://doi.org/10.1074/jbc.273.39.25272

[51]. Pocker, Y.; Meany, J. Biochemistry. 1967, 6, 239-246.
https://doi.org/10.1021/bi00853a037

[52]. Scozzafava, A.; Supuran, C. Met. Based Drugs. 1997, 4, 19-26.
https://doi.org/10.1155/MBD.1997.19

[53]. Shank, R. P.; Doose, D. R.; Streeter, A. J.; Bialer, M. Epilepsy Res. 2005, 63, 103-112.
https://doi.org/10.1016/j.eplepsyres.2005.01.001

[54]. Arslan, O. Biochemistry (Moscow). 2001, 66, 982-983.
https://doi.org/10.1023/A:1012365424900

[55]. Geary, W. J. Coord. Chem. Rev. 1971, 7, 81-122.
https://doi.org/10.1016/S0010-8545(00)80009-0

[56]. Pin, Y.; Xiaoping, Z. J. Inorg. Biochem. 1989, 37, 61-68.
https://doi.org/10.1016/0162-0134(89)80030-3

[57]. Aranha, P. E.; Dos Santos, M. P.; Romera, S.; Dockal, E. R. Polyhedron. 2007, 26, 1373-1382.
https://doi.org/10.1016/j.poly.2006.11.005

[58]. Ghosh, T.; Bhattacharya, S.; Das, A.; Mukherjee, G.; Drew, M. G. Inorganica Chim. Acta 2005, 358, 989-996.
https://doi.org/10.1016/j.ica.2004.11.015

[59]. Lever, A. Inorganic electronic spectroscopy.Amsterdam, New York : Elsevier. 1984.

[60]. Maples, D. L.; Maples, R. D.; Hoffert, W. A.; Parsell, T. H.; van Asselt, A.; Silversides, J. D.; Archibald S. J.; Hubin, T. J. Inorg. Chim. Acta 2009, 362, 2084-2088.
https://doi.org/10.1016/j.ica.2008.09.034

[61]. Bayoumi, H. A.; Alaghaz, A.-N. M.; Aljahdali, M. S. Int. J. Electrochem. Sc. 2013, 8, 9399-9413.

[62]. Horowitz, S. B.; Finley, B. L. Regul. Toxicol. Pharmacol. 1994, 19, 31-47.
https://doi.org/10.1006/rtph.1994.1003

[63]. Balamurugan, K.; Rajaram, R.; Ramasami, T. Mol. Cell. Biochem. 2004, 259, 43-51.
https://doi.org/10.1023/B:MCBI.0000021343.54495.8c

[64]. Balamurugan, K.; Rajaram, R.; Ramasami, T.; Narayanan, S. Free Radic. Biol. Med. 2002, 33, 1622-1640.
https://doi.org/10.1016/S0891-5849(02)01115-2

[65]. Nagai, R.; Mori, T.; Yamamoto, Y.; Kaji, Y.; Yonei, Y. Anti-Aging Med. 2010, 7, 112-119.
https://doi.org/10.3793/jaam.7.112

[66]. Povichit, N.; Phrutivorapongkul, A.; Suttajit, M.; Chaiyasut, C.; Leelapornpisid, P. Pak. J. Pharm. Sci. 2010, 23, 403-408.

[67]. Hadley, J.; Malik, N.; Meek, K. Micron. 2001, 32, 307-315.
https://doi.org/10.1016/S0968-4328(00)00032-9

[68]. Wu, C.H.; Yen, G.C. J. Agric. Food Chem. 2005, 53, 3167-3173.
https://doi.org/10.1021/jf048550u

[69]. Taha, M.; Naz, H.; Rasheed, S.; Ismail, N. H.; Rahman, A. A.; Yousuf, S.; Choudhary, M. I. Molecules. 2014, 19, 1286-1301.
https://doi.org/10.3390/molecules19011286

[70]. Choudhary, M. I.; Ali, M.; Wahab, A.T.; Khan, A.; Rasheed, S.; Shyaula, S. L.; Rahman, A. U. Sci. China Chem. 2011, 54, 1926-1931.
https://doi.org/10.1007/s11426-011-4436-2

[71]. Khan, K. M.; Khan, M.; Ali, M.; Taha, M.; Rasheed, S.; Perveen, S.; Choudhary, M. I. Bioorg. Med. Chem. 2009, 17, 7795-7801.
https://doi.org/10.1016/j.bmc.2009.09.028

[72]. Zeb, A.; Malik, I.; Rasheed, S.; Choudhary, M. I.; Basha, F. Z. Med. Chem. 2012, 8, 846-852.
https://doi.org/10.2174/157340612802084360

[73]. Baral, N.; Koner, B.; Karki, P.; Ramaprasad, C.; Lamsal, M.; Koirala, S. Singapore Med. J. 2000, 41, 264-267.

[74]. Ul-Hassan, M.; Chohan, Z. H.; Scozzafava, A.; Supuran, C. T. J. Enzyme Inhib. Med. Chem. 2004, 19, 263-267.
https://doi.org/10.1080/14756360410001689595


How to cite


Shamshad, B.; Jamal, R.; Ashiq, U.; Mahroof-Tahir, M.; Saleem, M. Eur. J. Chem. 2018, 9(3), 168-177. doi:10.5155/eurjchem.9.3.168-177.1735
Shamshad, B.; Jamal, R.; Ashiq, U.; Mahroof-Tahir, M.; Saleem, M. Cytotoxic, antiglycation and carbonic anhydrase inhibition studies of chromium(III)-aroylhydrazine complexes. Eur. J. Chem. 2018, 9(3), 168-177. doi:10.5155/eurjchem.9.3.168-177.1735
Shamshad, B., Jamal, R., Ashiq, U., Mahroof-Tahir, M., & Saleem, M. (2018). Cytotoxic, antiglycation and carbonic anhydrase inhibition studies of chromium(III)-aroylhydrazine complexes. European Journal of Chemistry, 9(3), 168-177. doi:10.5155/eurjchem.9.3.168-177.1735
Shamshad, Bushra, Rifat Ara Jamal, Uzma Ashiq, Mohammad Mahroof-Tahir, & Muhammad Saleem. "Cytotoxic, antiglycation and carbonic anhydrase inhibition studies of chromium(III)-aroylhydrazine complexes." European Journal of Chemistry [Online], 9.3 (2018): 168-177. Web. 16 Sep. 2021
Shamshad, Bushra, Jamal, Rifat, Ashiq, Uzma, Mahroof-Tahir, Mohammad, AND Saleem, Muhammad. "Cytotoxic, antiglycation and carbonic anhydrase inhibition studies of chromium(III)-aroylhydrazine complexes" European Journal of Chemistry [Online], Volume 9 Number 3 (30 September 2018)

The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item



DOI Link: https://doi.org/10.5155/eurjchem.9.3.168-177.1735

CrossRef | Scilit | GrowKudos | Researchgate | Publons | Microsoft | scibey | Scite | Lens | OUCI

WorldCat Paperbuzz | LibKey Citeas | Dimensions | Semanticscholar | Plumx | Kopernio | Zotero | Mendeley

ZoteroSave to Zotero MendeleySave to Mendeley



European Journal of Chemistry 2018, 9(3), 168-177 | doi: https://doi.org/10.5155/eurjchem.9.3.168-177.1735 | Get rights and content

Refbacks

  • There are currently no refbacks.


Bookmark and Share


Copyright (c) 2018 Authors

Creative Commons License
This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at http://www.eurjchem.com/index.php/eurjchem/pages/view/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (http://www.eurjchem.com/index.php/eurjchem/pages/view/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).


© Copyright 2010 - 2021 • Atlanta Publishing House LLC • All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2010-2021 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.